How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

October 21, 2026

Early Release – Community Transmission of Pneumonic Plague, Fenoarivobe, Madagascar, 2022 – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

October 21, 2026 No Comments

Infection Prevention: The First Line of Defense for Global Health

Prevention Is Where Patient Safety Begins International Infection Prevention Week is more than an annual

October 21, 2026 No Comments

Early Release – Disseminated Trimethoprim/Sulfamethoxazole–Resistant Nocardiosis in Renal Transplant Recipient, India – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

October 21, 2026 No Comments

Access Denied

Access Denied You don’t have permission to access “http://www.wpafb.af.mil/News/Article-Display/Article/4524063/afrls-711th-human-performance-wing-supports-hantavirus-response-in-omaha/” on this server. Reference #18.90c1c917.1792596606.59113b27 https://errors.edgesuite.net/18.90c1c917.1792596606.59113b27

October 21, 2026 No Comments

Early Release – Middle East Respiratory Syndrome Coronavirus in Camels, Kazakhstan, 2025 – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

October 21, 2026 No Comments

Too much RNA can starve cells of energy, scientists discover

Scientists have uncovered a surprising way that viruses can interfere with the body’s cells. When

October 21, 2026 No Comments

Early Release – Community Transmission of Pneumonic Plague, Fenoarivobe, Madagascar, 2022 – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Infection Prevention: The First Line of Defense for Global Health

Early Release – Disseminated Trimethoprim/Sulfamethoxazole–Resistant Nocardiosis in Renal Transplant Recipient, India – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Access Denied

Early Release – Middle East Respiratory Syndrome Coronavirus in Camels, Kazakhstan, 2025 – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Too much RNA can starve cells of energy, scientists discover

Schedule an Appointment

Quick Links

Patient Forms

Contact Us